The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled surviva
Similar stories
3 outlets
See how this story developed, hour by hour
US drug agency approves breakthrough treatment for pancreatic cancer
bbc.co.uk
27.08.2026
FDA Approves Rasonque for Pancreatic Cancer: When It’s Available and Cost
newsweek.com
26.08.2026
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
theguardian.com
26.08.2026